Doug Love was Appointed as Chief Executive Officer at Annexon Biosciences

Date of management change: December 15, 2014 

What Happened?

South San Francisco, CA-based Annexon Biosciences Appointed Doug Love as Chief Executive Officer


About the Company

Annexon Biosciences is leading the development of therapeutic products that halt the progression of complement-mediated neurodegeneration (CMND). Our antibody pipeline is based on breakthrough research involving the classical complement pathway and the unique role of its initiating molecule, C1q, in the loss of nerve connections and inflammation. Backed by a team of experts in CMND, our mission is to rapidly advance disease-modifying therapies for patients with Alzheimer`s disease, Huntington`s disease and other neurodegenerative disorders.


About the Person

Doug  Love is Chief Executive Officer at Annexon Biosciences. Previously, Doug  held various senior HR leadership roles in the industry.


Info Source



Other IT executives who recently changed jobs as well: Crane David, Elliott Catherine, De Guzman Danny, Kessler Valerie, Sanders Kenneth, Young Vicki, Cullen Vicky, Phelps Catherine, Cimorelli-Moor Karen, Zell Michelle, Kuhnz Tal

You can find the full directory of IT executives here.

How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.